BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Peng BG, Liang LJ, He Q, Kuang M, Lia JM, Lu MD, Huang JF. Tumor vaccine against recurrence of hepatocellular carcinoma. World J Gastroenterol 2005; 11(5): 700-704 [PMID: 15655825 DOI: 10.3748/wjg.v11.i5.700]
URL: https://www.wjgnet.com/1007-9327/full/v11/i5/700.htm
Number Citing Articles
1
Mengchao Wu, Feng Shen, Jiamei Yang, Weiping Zhou, Yiqun Yan, Xiaohui Fu. Primary Liver Cancer2012; : 399 doi: 10.1007/978-3-642-28702-2_13
2
Fumitoshi Hirokawa, Koji Komeda, Kohei Taniguchi, Mitsuhiro Asakuma, Tetsunosuke Shimizu, Yoshihiro Inoue, Shuji Kagota, Atsushi Tomioka, Kazuhiro Yamamoto, Kazuhisa Uchiyama. Is Postoperative Adjuvant Transcatheter Arterial Infusion Therapy Effective for Patients with Hepatocellular Carcinoma who Underwent Hepatectomy? A Prospective Randomized Controlled TrialAnnals of Surgical Oncology 2020; 27(11): 4143 doi: 10.1245/s10434-020-08699-w
3
Tim F Greten, Ghassan K Abou-Alfa, Ann-Lii Cheng, Austin G Duffy, Anthony B. El-Khoueiry, Richard S Finn, Peter R Galle, Lipika Goyal, Aiwu Ruth He, Ahmed O Kaseb, Robin Kate Kelley, Riccardo Lencioni, Amaia Lujambio, Donna Mabry Hrones, David J Pinato, Bruno Sangro, Roberto I Troisi, Andrea Wilson Woods, Thomas Yau, Andrew X Zhu, Ignacio Melero. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinomaJournal for ImmunoTherapy of Cancer 2021; 9(9): e002794 doi: 10.1136/jitc-2021-002794
4
Evangelia M Fatourou, John S Koskinas. Adaptive immunity in hepatocellular carcinoma: prognostic and therapeutic implicationsExpert Review of Anticancer Therapy 2009; 9(10): 1499 doi: 10.1586/era.09.103
5
Cheng-Long Han, Yu-Chuan Yan, Lun-Jie Yan, Guang-Xiao Meng, Chun-Cheng Yang, Hui Liu, Zi-Niu Ding, Zhao-Ru Dong, Jian-Guo Hong, Zhi-Qiang Chen, Tao Li. Efficacy and security of tumor vaccines for hepatocellular carcinoma: a systemic review and meta-analysis of the last 2 decadesJournal of Cancer Research and Clinical Oncology 2023; 149(4): 1425 doi: 10.1007/s00432-022-04008-y
6
Yanfang Zhang, Xuezhong Lei, Liangliang Xu, Xiaoju Lv, Mingqing Xu, Hong Tang. Preoperative and postoperative nomograms for predicting early recurrence of hepatocellular carcinoma without macrovascular invasion after curative resectionBMC Surgery 2022; 22(1) doi: 10.1186/s12893-022-01682-0
7
Jian‐Hong Zhong, Le‐Qun Li. Postoperative adjuvant transarterial chemoembolization for participants with hepatocellular carcinoma: A meta‐analysisHepatology Research 2010; 40(10): 943 doi: 10.1111/j.1872-034X.2010.00710.x
8
Philippe Fournier, Volker Schirrmacher. Randomized clinical studies of anti-tumor vaccination: state of the art in 2008Expert Review of Vaccines 2009; 8(1): 51 doi: 10.1586/14760584.8.1.51
9
Massimo Colombo, Jean-Luc Raoul, Riccardo Lencioni, Peter R. Galle, Jessica Zucman-Rossi, Rafael Bañares, Daniel Seehofer, Peter Neuhaus, Philip Johnson. Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinomaEuropean Journal of Gastroenterology & Hepatology 2013; 25(6): 639 doi: 10.1097/MEG.0b013e32835e33bb
10
K Sideras, S J Bots, K Biermann, D Sprengers, W G Polak, J N M IJzermans, R A de Man, Q Pan, S Sleijfer, M J Bruno, J Kwekkeboom. Tumour antigen expression in hepatocellular carcinoma in a low-endemic western areaBritish Journal of Cancer 2015; 112(12): 1911 doi: 10.1038/bjc.2015.92
11
Behnoud Baradaran Noveiry, Armin Hirbod‐Mobarakeh, Nastaran Khalili, Niloufar Hourshad, Tim F Greten, Ghassan K Abou‐Alfa, Nima Rezaei. Specific immunotherapy in hepatocellular cancer: A systematic reviewJournal of Gastroenterology and Hepatology 2017; 32(2): 339 doi: 10.1111/jgh.13449
12
Eric A. Mellon, Gilbert Murimwa, Sarah E. Hoffe. Radiation Therapy for Liver Tumors2017; : 269 doi: 10.1007/978-3-319-54531-8_20
13
Mark A Suckow, Julie Heinrich, Elliot D Rosen. Tissue vaccines for cancerExpert Review of Vaccines 2007; 6(6): 925 doi: 10.1586/14760584.6.6.925
14
Clifford Akateh, Sylvester M Black, Lanla Conteh, Eric D Miller, Anne Noonan, Eric Elliott, Timothy M Pawlik, Allan Tsung, Jordan M Cloyd. Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinomaWorld Journal of Gastroenterology 2019; 25(28): 3704-3721 doi: 10.3748/wjg.v25.i28.3704
15
John M. Kirkwood, Lisa H. Butterfield, Ahmad A. Tarhini, Hassane Zarour, Pawel Kalinski, Soldano Ferrone. Immunotherapy of cancer in 2012CA: A Cancer Journal for Clinicians 2012; 62(5): 309 doi: 10.3322/caac.20132
16
Yu Akazawa, Toshihiro Suzuki, Toshiaki Yoshikawa, Shoichi Mizuno, Yasunari Nakamoto, Tetsuya Nakatsura. Prospects for immunotherapy as a novel therapeutic strategy against hepatocellular carcinomaWorld Journal of Meta-Analysis 2019; 7(3): 80-95 doi: 10.13105/wjma.v7.i3.80
17
Hua He, Xiaojie Tu, Juan Zhang, Desmond Omane Acheampong, Li Ding, Zhaoxiong Ma, Xueyan Ren, Chen Luo, Zhiguo Chen, Tong Wang, Wei Xie, Min Wang. A novel antibody targeting CD24 and hepatocellular carcinoma in vivo by near-infrared fluorescence imagingImmunobiology 2015; 220(12): 1328 doi: 10.1016/j.imbio.2015.07.010
18
Xinglong Tong, Ling Wang, Yanping Liu, Yuqiao Qi, Yugou Qin, Yanping Xu, Tong Tong. The complete preventive effect of homologous tumor vaccines – Based on a 5-year experimental study in miceBiomedicine & Pharmacotherapy 2010; 64(9): 605 doi: 10.1016/j.biopha.2010.09.011
19
Ahmed Kaseb, Melanie Thomas. Hepatocellular Carcinoma2009; : 114 doi: 10.3109/9780203092880-10
20
Donald J. Bastin, Joshua Montroy, Michael A. Kennedy, Andre B. Martel, Risa Shorr, Maryam Ghiasi, Dominique M. Boucher, Boaz Wong, Louise Gresham, Jean-Simon Diallo, Dean A. Fergusson, Manoj M. Lalu, Natasha Kekre, Rebecca C. Auer. Safety and efficacy of autologous cell vaccines in solid tumors: a systematic review and meta-analysis of randomized control trialsScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-29630-9
21
Masatake Taniguchi, Shoichi Mizuno, Toshiaki Yoshikawa, Norihiro Fujinami, Motokazu Sugimoto, Shin Kobayashi, Shinichiro Takahashi, Masaru Konishi, Naoto Gotohda, Tetsuya Nakatsura. Peptide vaccine as an adjuvant therapy for glypican‐3‐positive hepatocellular carcinoma induces peptide‐specific CTLs and improves long prognosisCancer Science 2020; 111(8): 2747 doi: 10.1111/cas.14497
22
Stephen P Hack, Jessica Spahn, Minshan Chen, Ann-Lii Cheng, Ahmed Kaseb, Masatoshi Kudo, Han Chu Lee, Adam Yopp, Pierce Chow, Shukui Qin. IMbrave 050: a Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablationFuture Oncology 2020; 16(15): 975 doi: 10.2217/fon-2020-0162
23
Nobuhiro Tsuchiya, Yu Sawada, Itaru Endo, Yasushi Uemura, Tetsuya Nakatsura. Potentiality of immunotherapy against hepatocellular carcinomaWorld Journal of Gastroenterology 2015; 21(36): 10314-10326 doi: 10.3748/wjg.v21.i36.10314
24
Xiao Chen, Hai-Peng Liu, Mei Li, Liang Qiao. Advances in non-surgical management of primary liver cancerWorld Journal of Gastroenterology 2014; 20(44): 16630-16638 doi: 10.3748/wjg.v20.i44.16630